rna
structur
function
rna
interact
epitranscriptom
small
molecul
rnabas
therapeut
rna
diseas
drug
target
b
r
c
increas
appreci
crucial
role
rna
infecti
noninfecti
human
diseas
make
attract
therapeut
target
code
noncod
rna
frequent
fold
complex
conform
effect
target
offer
opportun
therapeut
modul
numer
cellular
process
includ
link
undrugg
protein
target
despit
consider
skeptic
whether
rna
target
small
molecul
therapeut
overwhelm
evid
suggest
challeng
current
face
outsid
realm
possibl
review
highlight
recent
advanc
molecular
techniqu
spark
revolut
understand
rna
structuretofunct
relationship
bring
attent
applic
modern
techniqu
identifi
druggabl
rna
target
assess
small
molecul
bind
specif
final
discuss
novel
screen
methodolog
support
rna
drug
discoveri
present
exampl
therapeut
valuabl
rna
target
vast
divers
rna
expand
beyond
code
transcript
sever
class
ncrna
vari
length
biogenesi
polar
put
function
increas
repertoir
druggabl
target
specif
rna
properti
contribut
attract
yet
challeng
makeup
target
molecul
rna
form
complex
threedimension
structur
canon
watsoncrick
base
pair
complex
tertiari
interact
mediat
noncanon
bond
structur
intric
stabl
form
protein
recogn
smallmolecul
ligand
nucleic
acid
andor
protein
high
affin
specif
time
highli
dynam
conform
repetit
charact
surfac
present
difficulti
drug
design
addit
mani
put
small
moleculebind
pocket
rna
much
polar
solvent
expos
bind
site
protein
complic
ligand
design
effort
compound
issu
target
rna
express
low
level
except
ribosom
rrna
transfer
trna
rna
constitut
total
cellular
rna
respect
abund
rna
messeng
mrna
small
nuclear
snrna
small
nucleolar
snorna
present
level
order
magnitud
lower
rrna
trna
certain
small
rna
micro
mirna
piwi
pirna
present
high
level
howev
appear
cell
type
depend
one
keep
mind
rna
catalyt
activ
act
scaffold
regul
http
doi
recent
advanc
field
rna
biolog
led
discoveri
plethora
code
noncod
nc
transcript
novel
mode
action
new
type
rna
epitranscriptom
modif
unforeseen
divers
mechan
lead
product
rna
discoveri
prompt
parallel
develop
modern
molecular
techniqu
provid
indepth
insight
rna
structur
function
biophys
character
rna
motif
xray
crystallographi
nuclear
magnet
reson
cryoelectron
microscopi
yield
solid
foundat
understand
chemic
structur
basi
rna
function
atom
resolut
howev
experiment
requir
methodolog
often
restrict
throughput
suitabl
studi
conform
heterogen
rna
addit
isol
rna
motif
fulllength
transcript
remov
rna
cellular
context
may
introduc
bias
final
conform
develop
rnacentr
deepsequenc
probe
techniqu
open
possibl
global
assess
rna
structur
singl
nucleotid
resolut
variou
biolog
context
addit
techniqu
address
rna
interact
effector
molecul
prompt
comprehens
myriad
molecular
pathway
involv
regulatori
rna
also
facilit
develop
high
affin
ligand
interfer
process
innov
creat
new
paradigm
field
biomedicin
rna
view
novel
larg
unexplor
drug
target
chromosom
architectur
case
mani
long
noncod
lncrna
rna
may
need
present
high
level
abl
perform
task
rna
stabil
anoth
detriment
aspect
need
consid
exampl
long
noncod
rna
lncrna
averag
shorter
halflif
median
h
messeng
rna
mrna
median
h
yet
intergen
cisantisens
well
splice
lncrna
cytoplasm
local
tend
challeng
rule
effort
therapeut
har
rna
began
soon
discov
even
though
function
well
understood
earli
rna
target
approach
reli
applic
aminoglycosid
potent
molecul
bind
bacteri
rrna
electrostat
interact
best
modest
select
system
toxic
despit
rather
unattract
physic
chemic
pharmacolog
synthet
characterist
remain
pillar
antibacteri
treatment
studi
rna
riboswitch
regulatori
element
bind
divers
metabolit
regul
gene
express
primarili
bacteria
show
small
metabolit
recogn
rna
remark
specif
discoveri
follow
develop
small
molecul
screen
function
defin
viral
rna
motif
human
immunodefici
transactiv
respons
element
tar
rna
interact
transactiv
transcript
tat
protein
rev
respons
element
rre
rev
protein
hepat
c
viru
hcv
intern
ribosom
entri
site
ire
studi
establish
rna
legitim
target
small
molecul
ligand
inde
bind
discret
bind
pocket
rna
cement
applic
smallmolecul
treatment
target
rna
compar
antisens
oligonucleotidebas
aso
strategi
pose
signific
limit
pharmaceut
agent
small
molecul
offer
uniqu
possibl
target
particular
rna
structur
element
chemic
biophys
tunabl
small
molecul
addit
overal
superior
cellular
tissu
permeabl
make
appeal
altern
addit
recogn
specif
hallmark
rna
fold
small
molecul
util
rna
structur
probe
yield
inform
rna
conform
exampl
methidiumpropyledta
mpe
appli
throughspac
cleavag
reagent
structur
interrog
fold
transit
substructur
despit
spectacular
advanc
rna
biolog
expert
field
still
face
long
list
consider
overal
three
major
compon
requir
support
develop
efficaci
rnabas
small
molecul
therapeut
identif
therapeut
valuabl
rna
target
develop
screen
method
establish
druglik
molecul
target
rna
identif
rna
motif
accommod
ligand
bind
high
affin
specif
review
discuss
modern
rnacentr
techniqu
har
elucid
rna
structuretofunct
relationship
potenti
applic
evalu
small
molecul
specif
shed
light
rna
properti
eg
stabil
level
express
structur
biolog
import
need
consid
given
transcript
design
druggabl
final
present
recent
develop
screen
strategi
support
identif
rnaspecif
ligand
highlight
newest
discoveri
field
therapeuticallyvalu
target
rna
knowledg
rna
biolog
import
regul
cellular
process
increas
becom
clear
specif
preponder
characterist
rna
structur
conform
dynam
may
influenc
whether
given
rna
target
effici
target
drug
past
wide
rang
chemic
enzym
use
monitor
rna
fold
dm
one
wellestablish
chemic
use
studi
rna
structur
highli
reactiv
solvent
access
unpair
residu
reliabl
unreact
base
engag
watsoncrick
interact
thu
nucleotid
strongli
protect
reactiv
dm
infer
basepair
unpair
respect
dm
treatment
recent
coupl
massiv
parallel
sequenc
readout
dmsseq
randomli
fragment
pool
modifi
rna
sizeselect
prior
ligat
specif
adapt
oligo
dm
modif
adenin
cytosin
residu
block
revers
transcript
rt
sequenc
fragment
reveal
precis
site
dm
modif
number
read
posit
provid
measur
rel
reactiv
site
dm
footprint
proven
tremend
versatil
method
appli
larg
fraction
known
structur
rna
well
probe
structur
modifi
rna
ligand
bind
rna
recent
year
group
electrophil
known
shape
reagent
becom
wide
use
highthroughput
rna
structur
probe
compound
preferenti
modifi
backbon
rna
structur
flexibl
singlestrand
region
react
group
ribos
gener
bulki
oadduct
choic
electrophil
tailor
specif
experiment
system
exampl
probe
react
rna
rapidli
well
suit
obtain
structur
snapshot
target
rna
electrophil
long
halflif
suitabl
studi
rna
slower
local
motion
shown
greater
potenti
govern
rna
fold
ligand
recognit
ribonucleoprotein
assembl
reaction
also
wide
palett
cellperm
probe
use
interrog
rna
fold
live
cell
yield
inform
rna
structur
chang
respons
variou
environment
stimuli
probe
select
follow
chemic
adduct
detect
involv
process
modifi
rna
sampl
perform
revers
transcript
rt
record
probe
modif
either
truncat
rtstop
mutat
rtmutat
result
cdna
sequenc
shape
mutat
profil
shapemap
exampl
rtmutat
method
recent
appli
live
cell
resolv
secondari
structur
lncrna
emerg
role
human
diseas
metastasi
associ
lung
adenocarcinoma
transcript
highli
abund
nuclear
transcript
associ
metastasi
nonsmal
cell
lung
cancer
polyadenyl
nuclear
pan
rna
key
regul
kaposi
sarcoma
associ
herpesviru
lytic
reactiv
xinact
specif
transcript
xist
transcript
orchestr
mammalian
xchromosom
inactiv
xci
name
led
increas
appreci
function
capabl
rna
structur
partit
function
base
pair
shapemap
datainform
shannon
entropi
calcul
yield
inform
divers
rna
conform
within
given
region
fig
gener
region
low
shape
reactiv
low
shannon
entropi
like
exist
singl
structur
state
found
highli
correl
known
function
rna
structur
potenti
repres
valuabl
drug
target
addit
shapemap
allow
research
studi
effect
small
molecul
bind
nativ
rna
structur
compar
analysi
yield
inform
whether
small
molecul
bind
also
specif
nucleotid
constitut
potenti
bind
site
effect
approach
proven
tar
thienopyridin
novel
tarspecif
ligand
howev
prior
version
rna
probe
method
name
shape
perform
vitro
transcrib
untransl
region
utr
valid
ligand
specif
coupl
systemat
mutagenesi
highthroughput
chemic
map
twodimension
mutateandmap
approach
expand
inform
content
rna
chemic
map
mutateandmap
seek
determin
chemic
reactiv
nucleotid
also
reactiv
affect
systemat
perturb
nucleotid
mutat
thu
provid
insight
tertiari
conform
well
valid
predict
structur
practic
mutat
might
lead
desir
releas
pair
partner
mutat
might
produc
larger
perturb
unfold
entir
helix
nevertheless
even
subset
probe
mutat
lead
precis
releas
interact
nucleotid
basepair
pattern
rna
could
potenti
read
extens
data
set
still
biochem
method
rna
structur
probe
live
cell
gener
averag
reactiv
profil
limit
capac
captur
complex
rna
structur
includ
longrang
structur
pseudoknot
altern
conform
psoralen
analysi
rna
interact
structur
pari
address
challeng
directli
identifi
basepair
helic
rnarna
interact
method
crosslink
perform
trioxsalen
amt
intercal
rna
helic
upon
photoactiv
crosslink
two
strand
prefer
stagger
uridin
rnase
proteinas
digest
follow
gel
electrophoresi
ensur
identifi
crosslink
repres
directli
basepair
rna
fragment
proxim
ligat
duplex
rna
fragment
photorevers
crosslink
high
throughput
sequenc
ultim
reveal
direct
base
pair
fragment
pari
read
give
individualmolecul
evid
duplex
two
rna
fragment
multipl
pari
read
thu
reveal
singl
common
structur
multipl
altern
structur
interact
two
rna
tran
pari
provid
inform
rna
preval
altern
conform
similarli
shannon
entropi
use
avoid
structur
dynam
poorli
defin
rna
region
small
molecul
target
rel
solvent
access
surfac
area
one
paramet
establish
previous
predict
magnitud
bindinginduc
conform
chang
biomolecul
structur
novel
chemic
probe
methodolog
name
light
activ
structur
examin
rna
laser
inform
rna
solvent
access
provid
addit
layer
structur
inform
particularli
rnaligand
complex
laser
use
lightgener
nicotinoyl
nitreniumion
naz
form
coval
adduct
posit
adenosin
guanosin
quantifi
either
rtstop
rtmutat
deepsequenc
author
verifi
applic
method
ligand
bind
detect
probe
bind
antimicrobi
peptid
rrna
addit
abovement
method
variou
bioinformat
tool
includ
rsampl
swellix
provid
insight
rna
altern
conform
rsampl
consid
multipl
copi
sequenc
simultan
fold
differ
conform
focus
agreement
experiment
map
data
estim
map
data
sampl
rna
structur
model
rather
interpret
data
absenc
techniqu
provid
principl
approach
integr
thermodynam
predict
map
data
hand
swellix
combin
possibl
helic
combinatori
approach
rna
fold
problem
order
comput
possibl
nonpseudoknot
rna
structur
softwar
includ
experiment
constraint
global
rna
structur
data
pair
constraint
phylogenet
analysi
selex
experi
chemic
enzymat
probe
experi
well
thermodynam
paramet
bioinformat
method
repres
complementari
tool
analyz
rna
sequenc
multipl
fold
overal
abovement
methodolog
led
muchimprov
appreci
ubiqu
function
capabl
rna
structur
provid
insight
rna
secondari
tertiari
structur
conform
chang
inform
potenti
featur
given
interact
target
rna
small
molecul
verifi
specif
interact
divers
role
rna
particularli
ncrna
often
consequ
complex
structur
importantli
structuremedi
interact
effector
molecul
eg
rna
dna
protein
fig
intermolecular
contact
increas
possibl
target
structur
eg
structur
space
ligand
bind
might
miss
less
structur
rna
recent
sever
biochem
method
develop
yield
inform
rna
interact
partner
rna
antisens
purif
raprna
reli
applic
crosslink
reagent
fix
endogen
rnarna
complex
live
cell
follow
rnaspecif
affin
purif
biotinyl
antisens
oligonucleotid
highthroughput
sequenc
raprna
perform
use
variou
crosslink
reagent
differenti
target
rna
direct
indirect
contact
transcript
instanc
direct
rnarna
interact
specif
captur
uv
amt
crosslink
indirect
interact
involv
protein
intermedi
captur
crosslink
formaldehyd
compar
similar
techniqu
distinct
featur
rap
use
long
captur
probe
tile
across
target
rna
allow
stringent
hybrid
wash
condit
significantli
reduc
nonspecif
background
rap
method
combin
quantit
mass
spectrometri
rapm
identifi
protein
directli
interact
specif
rna
vivo
rapm
use
uv
crosslink
creat
coval
bond
directli
interact
rna
protein
purifi
rna
target
specif
oligonucleotid
denatur
condit
disrupt
noncoval
interact
approach
use
method
crosslink
immunoprecipit
clip
known
identifi
direct
rnaprotein
interact
separ
interact
crosslink
cell
associ
solut
applic
raprna
rapm
reveal
function
intergen
repeat
rna
element
firr
interact
mb
region
flank
transcript
site
nuclear
matrix
factor
hnrnpu
process
anchor
inact
x
chromosom
nucleolu
also
rapm
provid
insight
novel
protein
factor
facilit
activ
xist
transcript
orchestr
xci
coat
silenc
one
x
chromosom
femal
rapm
allow
recogn
protein
activ
histon
deacetylas
also
compon
recruit
polycomb
repress
complex
across
x
exclud
rna
polymeras
ii
inact
x
data
togeth
recent
resolv
secondari
structur
entir
kb
xist
rna
provid
valuabl
find
acceler
small
molecul
target
xist
variou
diseas
chromatin
isol
rna
purif
chirp
domainspecif
chromatin
isol
rna
purif
dchirp
captur
hybrid
analysi
rna
target
chart
techniqu
use
identifi
genom
bind
site
rna
purifi
formaldehydecrosslink
complex
use
short
oligonucleotid
probe
direct
specif
rna
main
differ
techniqu
probe
chirp
tile
entir
target
rna
probe
dchirp
use
specif
pool
character
rna
domain
level
probe
chart
experiment
determin
rnase
h
assay
defin
access
hybrid
region
chirp
appli
reveal
genom
occup
two
therapeut
valuabl
lncrna
name
telomeras
rna
terc
hoxtranscript
antisens
rna
hotair
hotair
shown
function
key
regul
chromatin
state
dynam
recruit
affect
occup
gene
genomewid
associ
tumorigenesi
growth
invas
cancer
stem
cell
differenti
metastasi
drug
resist
consid
biomark
diagnost
therapeut
purpos
sever
cancer
terc
critic
rna
compon
telomeras
polymeras
serv
templat
enzym
telomeras
revers
transcriptas
tert
elong
telomer
variant
copynumb
chang
terc
locu
associ
cancer
risk
progress
neurodegen
diseas
given
abil
small
molecul
detect
rna
structur
element
target
specif
biomolecular
interact
tool
perfectli
pois
expand
palett
achiev
drug
target
recent
studi
identifi
distinct
epitranscriptom
rna
modif
preval
involv
addit
methyl
group
certain
posit
nucleobas
c
n
methyladenosin
predomin
epitranscriptom
modif
includ
isomer
uridin
pseudouridin
ribos
modif
adenosinetoinosin
edit
posttranscript
modif
expand
rna
function
capac
beyond
recogn
sequenc
structur
alon
time
offer
avenu
increas
specif
small
molecul
target
known
affect
rna
conform
function
metabol
epitranscriptom
consid
develop
adequ
tool
studi
rna
druggabl
differ
posit
methyl
carri
distinct
structur
consequ
rna
exampl
destabil
pair
uracil
alter
energet
au
pair
steric
hindranc
without
affect
pattern
hydrogenbond
donor
acceptor
presenc
reduc
rna
base
pair
stabil
vitro
vivo
creat
bind
site
protein
preferenti
recogn
modifi
base
fig
distinct
human
diseas
includ
development
disord
cancer
viral
infect
associ
dysregul
pattern
variou
cellular
transcript
also
two
site
detect
stem
loop
ii
rre
viral
rna
motif
focu
mani
current
past
target
effort
forc
scientist
rethink
strategi
effect
drugdesign
regulatori
function
c
yet
fulli
understood
shown
howev
vitro
methyl
affect
mg
bind
trna
molecul
influenc
anticodon
stem
loop
conform
stabil
secondari
structur
also
synthet
methyl
mrna
exhibit
increas
stabil
loss
methyl
utr
mrna
encod
tumor
suppressor
report
reduc
stabil
thu
like
c
affect
rna
stabil
function
live
cell
modif
carri
posit
charg
protrud
watsoncrick
hydrogenbond
face
adenin
result
nucleotid
remain
unpair
thu
dramat
alter
proteinrna
interact
rna
secondari
structur
electrostat
effect
map
uniqu
posit
near
translat
start
site
first
splice
site
code
transcript
correl
upregul
translat
isomer
uridin
known
pseudouridin
affect
rna
secondari
structur
increas
backbon
rigid
base
stack
due
prefer
conform
precis
pseudouridyl
pattern
role
human
rna
remain
partial
uncov
howev
base
heat
shock
induc
deposit
yeast
mrna
assum
increas
mrna
stabil
prevent
melt
rna
structur
protect
increas
temperatur
highthroughput
map
modifi
nucleosid
possibl
due
advanc
deepsequenc
technolog
gener
techniqu
fall
three
categori
immunoprecipit
fragment
rna
use
modificationspecif
antibodi
follow
sequenc
use
map
meripseq
ripseq
chemic
treatment
rna
prior
sequenc
exploit
differenti
reactiv
modifi
base
use
sodium
bisulfit
detect
c
bisulfateseq
cmc
carbodiimidemethoptoluenesulphon
detect
pseudouridin
nonrandom
mismatch
signatur
rna
sequenc
data
produc
revers
transcript
appli
miclip
modifi
dna
date
technolog
produc
transcriptomewid
map
abovement
epitranscriptom
modif
concurr
support
epitranscriptom
character
specif
code
nc
transcript
known
therapeut
valu
further
understand
discriminatori
potenti
specif
epitranscriptom
modif
hold
immens
promis
inform
design
rnabas
small
molecul
therapeut
also
sinc
rna
modif
known
contribut
immun
system
function
suppress
signal
innat
rna
sensor
find
contribut
second
come
rna
therapeut
develop
smallinterf
rna
rnabas
vaccin
mrna
therapeut
regularli
includ
modifi
compon
rna
strand
decreas
nucleas
sensit
reduc
activ
innat
immun
respons
last
decad
major
small
molecul
base
therapeut
strategi
focus
target
protein
mainli
studi
protein
structur
function
significantli
predat
rna
soon
enough
rna
revolut
reveal
rna
function
complex
directli
relat
rna
fold
often
critic
therapeut
intervent
pursu
date
small
molecul
found
regul
approxim
uniqu
diseaseassoci
mammalian
rna
apart
ribosom
rna
known
involv
finetun
mani
cellular
process
includ
cellular
differenti
homeostasi
immun
respons
prolifer
mani
contain
conserv
cisand
transact
motif
act
scaffold
site
rna
protein
influenc
subcellular
local
stabil
function
frequent
interact
sever
dysregul
varieti
human
disord
addit
mani
human
diseas
caus
rna
virus
dna
virus
whose
transcript
dysregul
cellular
function
expand
palett
potenti
rna
target
section
highlight
import
rna
structur
element
forefront
rnatarget
small
molecul
therapeut
report
recent
discov
small
molecul
modul
diseaseassoci
rna
element
mirna
posttranscript
gene
regul
bind
utr
target
mrna
inhibit
translat
caus
mirnamedi
degrad
biogenesi
transcript
begin
nucleu
local
primari
mirna
primirna
hairpin
digest
drosha
form
precursor
mirna
premirna
premirna
subsequ
transport
cytoplasm
process
dicer
follow
load
duplex
mirna
rnainduc
silenc
complex
risc
dysregul
mirna
contribut
varieti
human
diseas
includ
cancer
therefor
serv
potenti
small
molecul
target
cancer
research
purpos
mirna
divid
overexpress
target
tumor
suppressor
protein
decreas
express
cell
target
oncogen
princip
goal
mirnatarget
identifi
compound
potent
specif
bind
mirna
andor
upstream
precursor
therebi
decreas
level
li
et
al
describ
novel
small
molecul
bleomycin
conjug
select
bind
precursor
fig
found
upregul
mani
breast
cancer
associ
breast
cancer
prolifer
migrat
invas
vitro
well
tumor
growth
vivo
novel
chemotyp
specif
inhibit
drosha
process
lead
upregul
target
induct
apoptosi
michigan
cancer
breast
cancer
cell
anoth
crucial
cancerassoci
mirna
play
pivot
role
initi
progress
metastas
variou
cancer
gumireddi
et
al
discov
diazobenzen
deriv
small
molecul
inhibit
transcript
also
liu
et
al
describ
novel
small
molecul
sophocarpin
sc
downregul
express
head
neck
squamou
cell
carcinoma
hnscc
block
dicermedi
matur
dosedepend
manner
fig
sc
inhibit
hnscc
cell
prolifer
invas
metastasi
increas
express
tumor
suppressor
without
tissu
toxic
damag
show
promis
small
molecul
antitumor
therapeut
despit
report
success
mirnatarget
small
molecul
undergo
preclin
test
dispar
attribut
similar
secondari
structur
among
differ
mirna
cellular
rna
limit
select
specif
rna
target
yet
might
verg
resolv
issu
exampl
costal
et
al
recent
identifi
small
molecul
bind
two
target
precursor
hairpin
share
common
target
motif
new
studi
group
optim
dualselect
molecul
bind
one
target
use
secondari
structur
two
bind
site
model
identifi
addit
adjac
bind
site
present
use
fragmentbas
assembl
creat
molecul
select
parent
compound
new
site
new
molecul
bound
contain
origin
target
site
adjac
site
repress
sphingosin
kinas
key
enzym
phosphoryl
sphingosin
downstream
target
therebi
block
pathway
promot
cell
prolifer
migrat
human
breast
cancer
mechan
premrna
splice
complex
requir
interact
premrna
molecul
small
nuclear
ribonucleoprotein
splice
factor
protein
cisact
regulatori
sequenc
element
transact
protein
factor
variou
cellular
respons
add
anoth
layer
complex
alternativespl
premrna
lead
assemblag
variou
protein
isotyp
thu
mutat
within
splice
site
disrupt
regulatori
element
result
loss
function
reduc
specif
andor
truncat
protein
frequent
associ
human
diseas
spinal
muscular
atrophi
sma
sever
neurodegen
diseas
caus
loss
dysfunct
surviv
motor
neuron
gene
lead
caus
geneticrel
infant
death
fig
loss
result
degrad
lower
motor
neuron
spinal
cord
caus
symptom
hypotonia
sever
weak
due
neuromuscular
degrad
interestingli
sequenc
surviv
motor
neuron
gene
differ
singl
nucleotid
singl
nucleotid
chang
increas
rate
exon
exclus
splice
event
thu
produc
littl
function
smn
protein
increas
exon
inclus
mrna
small
molecul
could
therapeut
benefici
ptc
therapeut
discov
molecul
increas
product
ineffici
splice
fretbas
assay
fig
first
small
molecul
splice
modifi
enter
clinic
trial
drug
test
phase
trial
sma
patient
although
current
hold
due
safeti
find
novarti
basel
switzerland
also
identifi
small
molecul
work
via
stabil
transient
doublestrand
rna
structur
form
premrna
small
nuclear
ribonucl
protein
bind
caus
effici
splice
gene
therefor
increas
level
function
smn
protein
ongo
firstinhuman
studi
evalu
safeti
toler
potenti
benefit
type
sma
patient
month
age
discoveri
demonstr
feasibl
small
moleculemedi
rnaselect
splice
modul
well
potenti
leverag
strategi
splice
diseas
cancer
anoth
promis
exampl
splicingtarget
small
molecul
ellipticin
ligand
target
two
altern
splice
site
apoptosi
regul
bclx
premrna
bind
bclx
premrna
caus
direct
alter
splice
site
signifi
fluoresc
intens
increas
shift
emiss
peak
upon
interact
premrna
consist
direct
bind
interact
small
molecul
bclx
premrna
affect
overal
secondari
structur
close
x
x
l
site
region
respect
favor
format
stabl
conform
stem
loop
structur
addit
antagon
antiapoptot
isoform
bclx
favor
proapoptot
isoform
show
small
molecul
abil
induc
apoptosi
microsatellit
diseas
class
neurolog
neuromuscular
disord
caus
repeat
expans
expans
locat
open
read
frame
huntington
diseas
hd
untransl
region
myoton
muscular
dystrophi
type
fragil
xassoci
tremor
ataxia
syndrom
fxta
fragil
x
syndrom
fx
intron
amyotroph
later
sclerosi
al
myoton
dystrophi
type
fig
variou
group
tackl
target
rna
repeat
expans
small
molecul
wellstudi
rna
repeat
expans
trinucleotid
repeat
caus
r
cug
exp
bind
sequest
rbp
splice
regul
muscleblindlik
among
other
warf
et
al
identifi
small
molecul
pentamidin
disrupt
repeat
complex
pentamidin
disrupt
cug
rna
foci
releas
protein
sequestr
revers
aberr
altern
splice
commonli
seen
missplic
premrna
origin
pentamidin
believ
bind
r
cug
exp
howev
coonrod
et
al
attempt
identifi
exact
mechan
biophys
experi
fail
demonstr
signific
affin
pentamidin
cug
rna
repeat
seri
experi
scientist
suggest
pentamidin
may
interact
ctg
cag
repeat
dna
inhibit
transcript
howev
mechan
action
small
molecul
still
unknown
use
structur
r
cug
repeat
zimmerman
laboratori
design
small
molecul
compris
acridin
triaminotriazin
interact
rna
via
januswedg
hydrogen
bond
optim
firstgener
compound
result
three
bioactiv
compound
improv
missplic
format
nuclear
foci
cellular
drosophila
model
furthermor
disney
group
also
activ
identifi
inhibitor
differ
rna
repeat
includ
transcript
involv
fxta
recent
amyotroph
later
sclerosi
al
report
substitut
naphthyridin
identifi
highthroughput
screen
shown
inhibit
r
cug
exp
interact
use
fretbas
assay
cell
model
chemotyp
improv
premrna
splice
defect
caus
reduct
nuclear
foci
format
subsequ
compound
also
identifi
inhibitor
final
disney
laboratori
also
identifi
benzimidazol
screen
rnafocus
smallmolecul
librari
well
oligomer
hoechst
dyelik
compound
bind
r
cug
exp
cell
promis
effect
defect
cell
model
major
advantag
target
rna
expans
element
structur
well
document
lead
path
forward
effect
design
multival
molecul
high
specif
target
addit
mani
repeat
expans
disord
affect
central
nervou
system
small
molecul
easili
penetr
compet
antisens
oligonucleotid
current
two
therapeut
compani
name
ribometrix
arraki
therapeut
inc
lead
way
target
rna
expans
element
ribometrix
pursu
huntington
diseas
hd
target
myc
mrna
cancer
arraki
therapeut
inc
program
undisclos
repeat
expans
disord
neurolog
well
program
oncolog
rare
genet
diseas
rna
fold
altern
four
strand
secondari
structur
region
rich
guanin
call
gquadruplex
fig
gtetrad
four
guanin
arrang
squar
planar
arrang
held
togeth
hoogsteen
hydrogen
bond
stabil
achiev
presenc
monoval
cation
often
potassium
local
center
pair
tetrad
gquadruplex
first
describ
dna
yet
key
structur
differ
dna
rna
may
therapeut
target
gener
rna
higher
stabil
attribut
differ
hydrat
increas
intramolecular
hydrogen
bond
due
ribos
sugar
anoth
key
differ
dna
rna
presenc
methyl
group
uracil
absent
counterpart
thymin
present
dna
substitut
eoh
chemic
analogu
also
shown
destabil
gquadruplex
highlight
import
gquadruplex
structur
util
differ
rna
dna
increas
select
specif
avail
gquadruplex
ligand
toward
rna
recent
public
kwok
et
al
provid
comprehens
overview
predict
algorithm
structurebas
sequenc
method
util
transcriptomewid
detect
sinc
predict
form
mrna
encod
sever
oncogen
current
rnatarget
effort
focu
identifi
small
molecul
high
select
motif
proofofconcept
establish
use
report
construct
compris
utr
neuroblastoma
ra
oncogen
includ
gquadruplex
element
upstream
firefli
luciferas
gene
author
show
small
molecul
inhibit
translat
gquadruplexcontain
mrna
high
affin
select
motif
use
biotinstreptavidin
pulldown
assay
xodo
colleagu
identifi
small
molecul
bind
utr
kirsten
rat
sarcoma
kra
oncogen
human
kra
mutat
patient
pancreat
ductal
adenocarcinoma
pdac
lead
consid
crucial
target
anticanc
drug
author
identifi
two
compound
anthrafurandion
anthrathiophenedion
suppress
luciferas
express
express
construct
strongli
induc
apoptosi
reduc
metabol
activ
coloni
format
cell
carri
mutant
kra
recent
new
small
molecul
chemotyp
describ
bind
inhibit
rna
format
expand
g
c
g
c
exp
repeat
al
rna
transcrib
repeat
expans
sequest
rnabind
protein
produc
toxic
dipeptid
identifi
compound
shown
bind
gg
intern
loop
hairpin
structur
r
g
c
exp
prevent
format
rna
result
highlight
power
ration
design
small
molecul
target
therapeut
relev
rna
structur
due
elus
natur
verifi
exist
function
rna
gquadruplex
biolog
system
challeng
task
howev
newli
develop
method
transcriptomewid
identif
rna
gquadruplex
util
motifspecif
small
molecul
recent
report
precipit
sequenc
use
chemic
crosslink
step
follow
affin
captur
chemotyp
fig
target
identif
sequenc
captur
global
snapshot
transient
fold
techniqu
provid
insight
landscap
human
transcriptom
well
mean
studi
dynam
vivo
dynam
format
variou
biolog
condit
addit
activ
ligand
anoth
challeng
relat
gquadruplex
target
limit
select
typic
larg
flat
aromat
ligand
ligand
often
decor
proton
side
chain
necessari
loop
groov
interact
lower
overal
select
molecul
recent
develop
crystallographi
bioinformat
analys
may
key
unlock
uniqu
featur
structur
lead
develop
specif
potent
ligand
viral
rna
motif
viral
genom
highli
econom
come
genet
inform
encod
provid
narrow
number
protein
target
therapeut
intervent
recent
studi
aim
elucid
structur
conform
viral
rna
genom
virusencod
code
nc
transcript
greatli
expand
repertoir
drug
target
hiv
remain
thoroughli
studi
viru
multipl
rna
motif
investig
drug
target
fig
includ
tar
rre
also
dimer
initi
sequenc
di
packag
signal
gagpol
frameshift
signal
tar
element
resid
within
utr
viral
genom
serv
bind
site
tat
protein
format
tartat
complex
stimul
transcript
elong
yield
fulllength
viral
transcript
fragmentbas
screen
approach
identifi
ligand
hiv
tar
describ
colleagu
interrog
set
small
molecul
select
repres
molecular
motif
benefici
rna
recognit
also
benhida
cowork
pursu
design
approach
tar
rnabind
ligand
base
aminophenylthiazol
deriv
recent
schneekloth
colleagu
appli
small
molecul
microarray
smm
screen
fluoresc
label
tar
hairpin
identifi
select
chemotyp
fig
frequent
target
hiv
motif
includ
rre
locat
second
intron
viral
genom
rna
serv
highaffin
bind
site
rev
protein
rev
bind
rre
requir
nucleocytoplasm
export
fulllength
singli
splice
viral
transcript
two
studi
report
small
molecul
target
revrr
complex
none
approach
produc
inhibitor
show
antivir
activ
cell
recent
studi
shown
rre
carri
modif
play
critic
role
activ
rrerev
complex
serv
poignant
remind
authent
model
system
necessari
studi
rna
target
intern
ribosom
entri
site
ire
enabl
capindepend
translat
studi
therapeut
relev
target
polioviru
hepat
c
viru
hcv
fig
seth
colleagu
use
mass
spectrometrybas
screen
identifi
deriv
ligand
bind
intern
loop
rna
subdomain
iia
hcv
ire
use
rnatarget
small
molecul
librari
hermann
lab
discov
chemotyp
bind
ire
region
reduc
viral
replic
scientist
ibi
therapeut
also
discov
function
inhibitor
hcv
ire
rna
use
small
molecul
librari
mass
spectrometri
screen
method
fig
sever
acut
respiratori
syndrom
coronaviru
sarscov
frameshift
motif
includ
slipperi
sequenc
follow
pseudoknot
stall
ribosom
translat
also
explor
valuabl
rna
target
use
silico
screen
approach
park
colleagu
identifi
deriv
act
inhibitor
translat
frameshift
vitro
cellbas
assay
fig
recent
anoth
therapeut
approach
aim
disrupt
viral
latenc
emerg
weapon
herpesvirusassoci
infect
refer
shockandkil
therapi
strategi
aim
disrupt
viral
reservoir
reactiv
viral
product
follow
antivir
treatment
current
avail
latencyrevers
agent
herpesviru
infect
manipul
epigenet
pathway
use
histon
epigenet
modif
achiev
viral
reactiv
would
interest
see
specif
small
molecul
could
potenti
bind
viral
rna
caus
latenttolyt
switch
viral
infect
rnaspecif
small
molecul
repres
class
organ
compound
low
molecular
weight
specif
bind
rna
secondari
tertiari
structur
affect
rnaassoci
molecular
process
eg
translat
pattern
local
stabil
desir
featur
compound
interact
rna
intercal
sequenc
electrostat
complementar
mean
specif
molecular
recognit
event
uniqu
particular
rna
target
use
small
molecul
rnaspecif
druglik
compound
increas
due
frequent
desir
physicochem
characterist
includ
good
hydrophob
select
well
cell
tissu
permeabl
howev
caution
must
taken
examin
properti
might
follow
differ
set
principl
compar
one
coin
proteinspecif
small
molecul
recent
morgan
et
al
delv
understand
physicochem
structur
spatial
properti
rna
ligand
compil
rnatarget
bioactiv
ligand
databas
rbind
contain
list
bioactiv
monoval
small
molecul
multival
ligand
target
nonribosom
rna
overal
aim
databas
use
cheminformat
paramet
eg
oral
avail
lipinski
rule
veber
rule
structur
compon
molecular
complex
molecular
recognit
determin
trend
bioactiv
rna
ligand
section
highlight
novel
technolog
pave
way
discoveri
new
type
rnatarget
therapeut
fluoresc
base
assay
conveni
practic
tool
identifi
novel
nucleic
acidbind
ligand
mainli
due
sensit
speed
versatil
convent
fluoresc
assay
reli
incorpor
fluoresc
probe
rna
sequenc
might
impact
nativ
conform
side
effect
altern
approach
fluoresc
indic
displac
assay
fid
indic
display
differ
fluoresc
properti
presenc
absenc
oligonucleotid
therefor
util
measur
bind
properti
variou
chemotyp
fid
tagless
approach
mean
target
rna
ligand
investig
modifi
instead
fid
assay
util
intercal
dye
eg
trimethylammonio
propyl
methyl
benzothiazolium
topro
thiazol
orang
show
high
bind
affin
rna
frequent
requir
larg
quantiti
rna
recent
altern
method
reli
use
high
affin
rnaspecif
peptid
eg
hiv
tat
label
forster
reson
enhanc
transfer
fret
pair
specif
rnamotif
eg
tar
fig
peptid
bound
rna
fluorophor
distant
space
facilit
excit
donor
emiss
detect
acceptor
small
molecul
probe
displac
peptid
rna
fluorophor
proxim
emiss
acceptor
quench
quench
allow
quantif
bind
affin
small
molecul
toward
tar
rna
recent
hargrov
laboratori
extend
develop
fluoresc
peptid
displac
assay
screen
small
molecul
ligand
four
differ
rna
target
name
tat
bacteri
ribosom
asit
rna
iib
domain
respons
element
rna
rreiib
author
valid
method
quantifi
bind
aminoglycosid
known
rna
bind
small
molecul
four
rna
target
advanc
electrospray
ioniz
esi
matrixassist
laser
desorptionion
maldi
decreas
sampl
requir
increas
mass
rang
result
mass
spectrometri
ms
increasingli
util
screen
target
smallmolecul
inhibitor
ms
screen
tool
advantag
neither
target
potenti
ligand
requir
label
deconvolut
inform
stoichiometri
cooper
rel
bind
affin
determin
quickli
within
singl
sampl
solut
low
concentr
maldi
use
puls
laser
desorpt
ion
timeofflight
analyz
success
use
combin
esi
metabolit
profil
model
small
interf
rna
sirna
duplex
tsr
esi
mass
spectrometri
esim
greater
util
studi
noncoval
molecular
interact
gener
molecular
ion
littl
fragment
one
first
applic
esim
result
identif
specif
bind
intern
ribosom
entri
site
iia
subdomain
hepat
c
viru
result
reduct
hcv
rna
replic
also
esim
use
dremann
et
al
identifi
rnapeptid
complex
specif
bacteri
ribosom
helix
fouriertransform
ion
cyclotron
reson
fticr
ms
provid
highresolut
spectra
isotoperesolv
precursor
ion
select
accur
mass
assign
fticr
ms
use
studi
interact
two
close
relat
model
rna
construct
correspond
decod
site
prokaryot
eukaryot
rrna
collect
aminoglycosid
antibiot
autom
ligand
identif
system
ali
labelfre
asm
platform
novel
msbase
approach
allow
highthroughput
screen
small
molecul
larg
combinatori
mixtur
test
bind
target
macromolecul
coupl
fast
size
exclus
chromatographi
sec
separ
free
ligand
targetligand
complex
integr
lcm
ligand
identif
singl
ali
instrument
screen
hundr
thousand
compound
day
minim
labelfre
target
consumpt
unlik
direct
asm
method
reli
ms
detect
intact
targetligand
complex
ali
indirect
asm
techniqu
use
sizeexclus
chromatographi
resolv
targetligand
complex
unbound
speci
dissoci
ligand
complex
use
denatur
condit
employ
ms
identifi
previous
bound
ligand
ali
recent
use
identifi
character
two
rna
ligand
competit
bind
flavin
mononucleotid
fmn
riboswitch
exhibit
druglik
function
capabl
potent
analog
ellipticin
quinolon
class
antibacteri
respect
msbase
screen
aid
discoveri
novel
chemic
class
bind
rna
may
miss
nonbiophys
screen
approach
smm
highthroughput
technolog
screen
larg
unbias
librari
druglik
small
molecul
microarray
format
target
rna
fig
techniqu
collect
small
molecul
ie
primari
secondari
alcohol
amin
spatial
array
robot
microarray
coval
link
glass
surfac
high
densiti
microarray
incub
fluorescentlylabel
target
rna
follow
wash
remov
unspecif
bind
slide
imag
use
fluoresc
scanner
fluoresc
intens
quantifi
spot
array
statist
analysi
reveal
spot
increas
fluoresc
upon
incub
correspond
discret
molecular
interact
target
rna
associ
small
molecul
smm
becom
establish
choic
platform
screen
lead
discoveri
molecular
character
rnaspecif
binder
exampl
smm
appli
discov
chemotyp
specif
recogn
bind
hiv
tar
hairpin
fig
bind
specif
identifi
small
molecul
valid
shape
probe
perform
hiv
utr
presenc
absenc
chemotyp
confirm
ligand
bind
b
small
molecul
microarray
screen
approach
smm
fluoresc
label
target
rna
motif
incub
array
follow
detect
fluoresc
increas
bind
event
right
side
repres
raw
smm
imag
hit
structur
compound
print
duplic
control
buffer
c
microscal
thermophoresi
mst
perform
thin
capillari
blue
free
solut
microscop
temperatur
gradient
induc
infrar
laser
ir
temperatur
relat
intens
chang
well
thermophoresi
detect
initi
molecul
homogen
distribut
constant
initi
fluoresc
detect
activ
ir
laser
rapid
chang
fluorophor
properti
due
fast
temperatur
chang
note
subsequ
thermophoret
movement
fluorescenc
label
molecul
heat
sampl
volum
detect
overal
mst
signal
plot
ligand
concentr
obtain
doserespons
curv
right
twodimension
combinatori
screen
select
privileg
rna
motif
specif
ligand
simultan
screen
nucleic
acid
librari
small
molecul
librari
chemic
immobil
microarray
format
gradient
concentr
row
repres
decreas
concentr
uniqu
chemicalsmal
molecul
rna
librari
allow
react
hybrid
microarray
unbound
rna
wash
away
bound
fraction
excis
rna
extract
sequenc
identifi
featur
allow
bind
small
molecul
e
fragmentbas
drug
discoveri
fbdd
includ
unbias
divers
fragment
set
test
target
rna
use
differ
biophys
eg
nmr
andor
biochem
eg
shape
screen
approach
lead
hit
identif
structurel
optim
specif
tar
hairpin
also
recent
connelli
et
al
use
smm
approach
identifi
novel
small
molecul
select
bind
proxim
apic
loop
hairpin
prevent
biogenesi
dicer
inhibit
fig
bind
specif
overal
affin
identifi
druglik
chemotyp
valid
differenti
scan
fluorimetri
dsf
fluoresc
titrat
fluoresc
intens
assay
absorb
array
recent
advanc
smm
technolog
develop
disney
laboratori
small
molecul
compound
noncoval
absorb
onto
hydrat
agaroseco
microarray
surfac
creat
chemic
unmodifi
librari
bind
radiolabel
rna
motif
librari
approach
meant
avoid
addit
function
group
coval
immobil
chemotyp
array
could
influenc
molecular
recognit
parent
compound
natur
target
absorb
array
appli
nih
clinic
collect
librari
rnafocus
small
molecul
rna
splice
modul
librari
kinas
inhibitor
confirm
drug
particular
topoisomeras
inhibitor
kinas
inhibitor
rna
splice
modul
bind
rna
understand
biophys
characterist
rnabas
small
molecul
therapeut
equal
import
discoveri
lead
compound
microscal
thermophoresi
mst
biophys
techniqu
use
identifi
quantifi
interact
biomolecul
includ
protein
dna
rna
peptid
small
molecul
closeton
condit
fig
quantifi
intermolecular
interact
infraredlas
use
achiev
precis
microscal
temperatur
gradient
within
glass
capillari
fill
target
solut
eg
cell
lysat
serum
bioliquid
direct
movement
biomolecul
microscal
temperatur
gradient
allow
quantif
chang
within
chemic
microenviron
fluorescentlylabel
target
biomolecul
interact
nonfluorescentlylabel
ligand
turn
identifi
bind
affin
discrimin
differ
bind
site
target
biomolecul
schneekloth
laboratori
recent
explor
util
mst
probe
hiv
rreneomycin
hiv
rrerev
peptid
interact
also
examin
competit
rre
rna
bind
neomycin
rev
peptid
via
two
differ
approach
applic
mst
effect
measur
bind
affin
result
agre
previous
report
valu
determin
via
differ
biophys
techniqu
also
disney
laboratori
util
mst
character
bind
affin
small
molecul
u
bulg
oncomir
particular
chemotyp
found
inhibit
level
matur
concomitantli
increas
level
revers
invas
phenotyp
caus
elev
express
tripleneg
breast
cancer
cell
capac
mst
monitor
therapeut
relev
rna
bind
event
competit
displac
connect
high
sensit
small
volum
sampl
requir
analysi
make
attract
screen
platform
discov
rnaspecif
small
molecul
libraryversuslibrari
selectionbas
screen
approach
identifi
small
molecul
chemotyp
highaffin
select
small
rna
secondari
structur
ie
hairpin
intern
loop
bulg
fig
first
small
molecul
librari
conjug
sitespecif
onto
agaros
microarray
chemic
array
probe
bind
librari
label
rna
motif
along
competitor
oligonucleotid
incub
analyz
rna
motifligand
interact
hit
rna
motif
excis
array
quantifi
sequenc
follow
sequenc
rna
bindingsmal
molecul
interact
analyz
structureact
relationship
sequenc
start
highthroughput
structureact
relationship
sequenc
hitstart
use
statist
approach
determin
rna
motif
fit
affin
select
specif
small
molecul
start
util
identifi
posit
neg
featur
rna
motif
target
may
impact
small
molecul
affin
assign
score
base
upon
rna
motifligand
interact
hitstart
defin
rnasmal
molecul
affin
landscap
score
rnamotif
small
molecul
bind
partner
gener
structureact
relationship
base
data
collect
nextgener
sequenc
rnaseq
experiment
determin
affin
start
hitstart
use
tandem
inforna
bioinformaticsbas
approach
integr
rna
motifsmal
molecul
interact
identifi
via
structur
data
target
rna
inforna
gener
lead
compound
rna
interest
compar
motif
found
rna
target
structur
rna
motifsmallmolecul
interact
databas
integr
hitstart
inforna
led
discoveri
small
molecul
chemotyp
bind
inhibit
biogenesi
inforna
also
appli
analyz
secondari
structur
mirna
match
rna
motifsmal
molecul
pair
precis
link
modul
bind
near
drosha
process
site
yield
fig
chemotyp
enabl
select
target
subsequ
inhibit
drosha
process
breast
cancer
similar
approach
appli
identifi
fig
small
molecul
modul
product
lead
increas
apoptosi
tripleneg
breast
cancer
cell
via
hypoxia
induc
factor
hif
pathway
result
studi
led
author
propos
broad
guidelin
mirna
target
allevi
oncogen
phenotyp
suggest
bind
must
occur
function
activ
region
eg
dicer
drosha
process
region
ligand
must
bind
site
high
affin
rna
abund
molecul
affin
affect
target
occup
necessari
elicit
biolog
respons
fragmentbas
drug
discoveri
fbdd
biochem
biophys
approach
use
identifi
lead
druglik
compound
though
identif
character
multipl
small
chemic
fragment
bind
rna
fig
small
size
fragment
enhanc
hit
rate
target
sinc
form
less
destruct
steric
interact
target
compar
larger
compound
addit
argu
size
fragment
chemic
space
substanti
smaller
chemic
space
larger
druglik
space
sampl
effici
identifi
compound
may
elabor
via
multipl
strategi
potent
select
inhibitor
overal
fbdd
screen
approach
includ
fragment
librari
target
enabl
screen
chemic
fragment
biophys
biochem
assay
identifi
fragment
hit
gener
fragmentbind
model
biophys
character
structur
determin
fragment
lead
druglik
compound
optim
medicin
chemistri
character
fragment
earli
fragment
link
studi
identifi
novel
smallmolecul
ligand
ribosom
antibiot
bind
site
benzimidazol
hit
fragment
intern
loop
within
domain
ii
hcv
ire
use
grow
set
ligand
bind
affin
micromolar
rang
seri
reduc
hcv
rna
level
hcv
replicon
assay
minim
toxic
initi
ligand
effort
origin
larg
gener
highthroughput
screen
librari
recent
fragment
librari
design
specif
fragment
screen
rna
target
advantag
approach
use
rnadirect
fragment
librari
physicochem
properti
fragment
much
favor
classic
medicin
chemistri
origin
compound
recent
fbdd
screen
approach
appli
target
telomer
repeatcontain
terra
rna
result
identif
hit
librari
fluorin
fragment
compound
abl
specif
recogn
parallel
propel
structur
compound
interact
dna
analog
terra
compound
shown
favor
parallel
conform
predomin
conform
rna
gquadruplex
present
terra
result
suggest
ligand
select
strong
prefer
parallel
propellerlik
conform
found
telomer
sequenc
context
viral
rna
fbdd
approach
use
identifi
ligand
hiv
tar
element
colleagu
interrog
set
small
molecul
select
repres
molecular
motif
benefici
rna
recognit
fragment
rich
chemotyp
provid
hydrogen
bond
donor
includ
amin
amidin
guanidin
well
benzen
ring
stack
interact
fluorometr
competit
assay
determin
seven
small
molecul
compound
abl
displac
dye
label
tat
peptid
tar
rna
also
lee
et
al
report
fragmentbas
screen
small
molecul
bind
influenza
viru
promot
overal
valu
fragmentbas
approach
may
develop
lead
specif
rna
structur
also
help
assess
druggabl
newli
discov
rna
structur
compar
chemotyp
screen
method
fbdd
allow
select
weak
fragment
highli
special
target
rna
molecul
base
initi
hit
also
target
rna
nmr
spectroscopi
crystal
structur
thu
creat
highli
potent
rnaspecif
therapeut
furthermor
fbdd
assess
whether
rna
target
druggabl
amount
strength
specif
weak
binder
hit
eg
littl
hit
specif
rna
like
structur
element
inhibit
bind
small
molecul
varieti
rna
target
therapeut
intervent
stagger
span
viral
regulatori
rna
motif
code
ncrna
involv
infecti
noninfecti
human
diseas
also
mostli
unexplor
potenti
target
novel
rna
speci
circular
rna
antisens
rna
lncrna
addit
rnamedi
interact
often
dysregul
varieti
human
disord
widen
pallet
druggabl
target
aberr
interact
rna
protein
wellrecogn
factor
lead
rna
gainoffunct
mechan
underlin
repeat
expans
disord
discuss
achiev
therapeut
effect
rnaspecif
chemotyp
would
need
specif
recogn
bind
disrupt
rna
prevent
protein
bind
bind
protein
would
inhibit
cellular
function
like
caus
advers
effect
convers
case
lossoffunct
disord
decreas
protein
bind
therapeut
small
molecul
need
enhanc
protein
bind
shown
small
molecul
ligand
bind
premrna
alter
altern
splice
advanc
method
enabl
character
nativ
rna
structur
function
cellular
local
intermolecular
interact
expand
alreadi
broad
select
potenti
therapeut
target
small
molecul
util
inform
gain
studi
rna
variou
biolog
vitro
system
certainli
acceler
progress
rnaspecif
drug
design
howev
rna
deriv
differ
biolog
system
may
repres
distinct
challeng
drug
target
regardless
biolog
pharmacolog
signific
rel
express
target
rna
cell
local
structur
access
function
site
ligand
bind
certainli
affect
druggabl
anoth
challeng
overcom
issu
specif
select
major
barrier
rnabind
molecul
exampl
rrna
constitut
vast
major
cellular
rna
ncrna
collect
constitut
less
total
cellular
rna
thu
target
one
ncrna
select
might
challeng
howev
implement
structurebas
highthroughput
screen
method
discuss
proven
effect
identifi
new
small
molecul
chemotyp
good
specif
high
affin
also
flexibl
rnaspecif
small
molecul
aid
construct
effect
multifunct
drug
one
mode
action
affect
multipl
target
could
replac
drug
cocktail
lesson
learn
effort
ligand
discoveri
structur
rna
element
includ
regulatori
motif
virus
bacteri
rrna
ncrna
may
inspir
futur
search
inhibitor
target
rna
motif
wide
rang
human
disord
addit
novel
tool
emerg
speak
rang
nanopor
sequenc
detect
rna
base
modif
http
wwwbiorxivorgcont
artifici
intelligencedriven
drug
design
soon
offer
new
insight
rna
biolog
provid
signific
step
forward
develop
novel
much
need
therapeut
jss
gcc
sec
contribut
manuscript
write
figur
prepar
